Home
Conditions
Uterine Cervical Neoplasms

Clinical trial condition

Uterine Cervical Neoplasms

Explore clinical trials studying Uterine Cervical Neoplasms. Study availability and eligibility vary by location and protocol.

1,590 public trials 356 recruiting studies

Refine in advanced search Browse all conditions

Uterine Cervical Neoplasms trial results

Completed

Feasibility and Acceptability of HPV Self-Collection Cervical Cancer Screening and Treatment in Botswana

NCT03345875

Conditions: Cervical Cancer, Communicable Diseases, DNA Virus Infections, +23 more
Locations: Kopong Health Clinic Kopong, Botswana

Lephepe Health Clinic Lephepe, Botswana

Phuthadikobo Molepolole, Botswana

Scottish Livingstone Hospital Molepolole, Botswana

View Trial Details

Completed

Physical Activities by Technology Help (PATH)

NCT03212079

Conditions: Behavior, Breast Cancer, Breast Diseases, +45 more
Locations: Johns Hopkins Bloomberg School of Public Health Baltimore, Maryland, United States

View Trial Details

Completed

Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients

NCT00268918

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +29 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Determining the Sensitivity of Sentinel Lymph Nodes Identified With Robotic Fluorescence Imaging

NCT01673022

Conditions: Cervical Cancer, Endometrial Cancer, Endometrial Neoplasms, +13 more
Locations: USA Mitchell Cancer Institute Mobile, Alabama, United States

Indiana University Indianapolis, Indiana, United States

St. Elizabeth Healthcare Edgewood, Kentucky, United States

Sunrise Hospital and Medical Center Las Vegas, Nevada, United States

View Trial Details

Completed

A Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine/Cervarix TM Vaccine in Healthy Females Aged 15-25 Years

NCT00485732

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations: GSK Investigational Site Seoul, South Korea

GSK Investigational Site Seoul, South Korea

GSK Investigational Site Seoul, South Korea

GSK Investigational Site Seoul, South Korea

View Trial Details

Completed

Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years

NCT00345878

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations: GSK Investigational Site Kerajaan Persekutuan Putrajaya, Malaysia

GSK Investigational Site Kuala Lumpur, Malaysia

View Trial Details

Completed

A Single Centre Study to Evaluate the Safety and Immunogenicity of the Human Papillomavirus Vaccine (GSK-580299) in Chinese Females

NCT00549900

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations: GSK Investigational Site Jintan, Jiangsu, China

View Trial Details

Completed

Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia

NCT00121173

Conditions: Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Sexual Functioning in Cervical Cancer Survivors

NCT00522223

Conditions: Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Randomised Controlled Trial Between Two Different HDR Brachytherapy Schedule in Locally Advanced Carcinoma of Uterine Cervix

NCT02765919

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +11 more
Locations: BSM Medical University Dhaka, Bangladesh

View Trial Details

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms trial results

Related conditions